Boosting of HIV envelope CD4 binding site antibodies with long variable heavy third complementarity determining region in the randomized double blind RV305 HIV-1 vaccine trial.
Easterhoff, D., Moody, M.A., Fera, D., Cheng, H., Ackerman, M., Wiehe, K., Saunders, K.O., Pollara, J., Vandergrift, N., Parks, R., Kim, J., Michael, N.L., O'Connell, R.J., Excler, J.L., Robb, M.L., Vasan, S., Rerks-Ngarm, S., Kaewkungwal, J., Pitisuttithum, P., Nitayaphan, S., Sinangil, F., Tartaglia, J., Phogat, S., Kepler, T.B., Alam, S.M., Liao, H.X., Ferrari, G., Seaman, M.S., Montefiori, D.C., Tomaras, G.D., Harrison, S.C., Haynes, B.F.
PLoS Pathog.